Carnoy solution versus GEWF solution for lymph node revealing in colorectal cancer: a randomized controlled trial
Tiago L Ghezzi1,2,3, Márcia P Pereira4, Oly C Corleta5
1Division of Coloproctology, Hospital Moinhos de Vento, 2350 Ramiro Barcelos St, 600, Porto Alegre, RS, 90035-903, Brazil. tghezzi@hcpa.edu.br.
International Journal of Colorectal Disease
|November 16, 2019
Summary
Two lymph node revealing solutions, Carnoy and GEWF, increased lymph node retrieval in colon and rectal cancer surgery. However, neither solution significantly altered patient staging or treatment indications compared to conventional methods.
Area of Science:
- Oncology
- Surgical Pathology
- Cancer Research
Background:
- Accurate lymph node staging is crucial for colon and rectal cancer treatment.
- Conventional pathological examination may miss some lymph nodes.
- Novel solutions aim to improve lymph node retrieval during surgical resection.
Purpose of the Study:
- To compare the performance of Carnoy solution and GEWF solution in enhancing lymph node retrieval during colon and rectal cancer surgery.
- To evaluate the impact of these solutions on identifying additional metastatic lymph nodes and subsequent patient staging.
Main Methods:
- A randomized clinical trial (NTC02704988) involving patients with colon or rectal cancer undergoing D2 lymphadenectomy.
- Surgical specimens were randomly assigned for conventional examination or additional fixation with Carnoy or GEWF solution.
- Key outcomes included the number of lymph nodes retrieved, additional metastatic lymph nodes identified, lymph node upstaging, and adjuvant therapy indications.
Main Results:
- Both Carnoy and GEWF solutions significantly increased the number of lymph nodes retrieved in both colon and rectal cancer patients compared to the conventional method.
- No significant differences were observed between the solutions and conventional examination regarding the number of additional metastatic lymph nodes identified.
- Lymph node upstaging and complementary indications for adjuvant therapy were not significantly altered by the use of either solution.
Conclusions:
- While Carnoy and GEWF solutions enhance lymph node retrieval, they do not significantly improve patient staging or change treatment decisions in colon and rectal cancer.
- Both lymph node revealing solutions demonstrated comparable performance in all assessed outcomes.
- Further research may explore the clinical significance of increased lymph node yield in specific patient subgroups.


